WA-GEMATEG
13.5.2024 13:01:27 CEST | Business Wire | Press release
GemaTEG™ introduces DaTEG 1.0, a thermal management solution that significantly reduces energy costs and enhances chip performance in AI infrastructures.
Why It Matters
- As the AI industry's appetite for computing power grows, so does the strain on data center infrastructure.
- Traditional cooling systems are energy-intensive and often lack efficiency.
- GemaTEG's DaTEG 1.0 helps top chip designers in the HPC industry, hyper-scalers, data center providers, and systems integrators transcend AI industry limitations by enhancing capacity without increasing resource demands.
What’s new
- DaTEG 1.0 is an integrated and modular Thermal Management solution that takes far less server space than traditional, less efficient cooling technologies.
- The breakthrough lies in its ability to maintain peak operational conditions for GPUs and CPUs, thereby extending their longevity and enhancing their output.
Deep Background
- Developed by astroparticle physicist Maurizio Miozza (Co-Founder and CTO) from decades of experience in silicon properties, DaTEG 1.0 results from over five years of research in materials science and fluid dynamics.
- The technology incorporates advances from aerospace to nuclear science, providing an integrated cooling solution.
By the Numbers
- DaTEG 1.0 supports chips consuming up to 500 watts, with future enhancements to accommodate chip designs of up to 1000 watts.
- Testing shows potential performance reaches advertised GHz levels without the risk of overheating—critical for maintaining uptime for AI in data centers.
Expert Voice
- From Maurizio Miozza: "With DaTEG, we're not just preventing chips from overheating; we're optimizing their operational conditions to push the boundaries of what's possible in AI computing."
What's Next
- GemaTEG is collaborating with global academic and industry leaders to refine and expand the capabilities of DaTEG, ensuring it meets the future needs of AI infrastructure.
Learn More
- For more information on DaTEG 1.0 and its impact on sustainable, efficient data center operations, visit the newly launched website at www.gemateg.com.
GemaTEG: Accelerating AI Infrastructure
GemaTEG’s Thermal Management solution transcends AI industry limitations by enhancing capacity without increasing resource demands.
Founded in 2019, GemaTEG is on a mission to accelerate AI infrastructure by leveraging its deep science expertise with environmental responsibility to create Thermal Management advancements that boost performance, reduce costs, and improve sustainability for all stakeholders.
Visit www.gemateg.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240513731840/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Splio Enters a New Phase of Its Regional Development in Southern Europe19.5.2026 09:00:00 CEST | Press release
As consumers integrate AI into their everyday web usage, Splio is strengthening its presence in Barcelona to help companies across the region make CRM a central lever in the age of agentic commerce Splio is strengthening its presence in Barcelona, which is set to play the role of a second headquarters, to drive its development across Southern Europe.Splio is reinforcing governance, teams and resources deployed in the region.With its AI-first CRM, Splio aims to help companies from retail to travel strengthen the business contribution of CRM. A few months after launching its AI-first CRM, Splio is entering a new phase of its development in Southern Europe. Already established for more than 12 years in Spain, Portugal and Italy, the company has chosen to invest further in the region, convinced that it combines economic potential with rapidly evolving digital usage. Antoine Parizot, Splio’s co-CEO, is relocating to Barcelona, where the company’s historic office is based. At the same time,
KfW, Germany’s largest national promotional bank, future-proofs regulatory reporting, by migrating to Regnology Reporting Hub (RRH)19.5.2026 08:33:00 CEST | Press release
Longstanding client transitions to the next-generation RRH solution, delivered on Regnology’s Rcloud architecture Regnology, a leading provider at the intersection of regulatory, risk, and supervisory technology, today announced that KfW Bankengruppe (KfW) is advancing its long-term partnership with the company by electing to migrate to the next-generation Regulatory Reporting Hub (RRH). The solution will be delivered as a cloud-native service on Rcloud, Regnology’s high-performance cloud architecture layer. This strategic move to the modern RRH platform future-proofs the mission-critical reporting functions for one of the world's leading promotional banks. Headquartered in Frankfurt am Main, KfW is a public‑law institution dedicated to supporting sustainable economic, social and ecological development in Germany, across Europe and globally. Regnology’s foresight led to the 2023 launch of Rcloud, its state-of-the-art architecture layer built on Google Cloud, enabling next‑generation so
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth19.5.2026 08:00:00 CEST | Press release
ATB Therapeutics (“ATB” or the “Company”), a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, today announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The leadership transition marks an important milestone as the Company continues its evolution from a startup into a development-stage biopharmaceutical company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513198633/en/ ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth Mark Throsby has served as Executive Chairman and Chief Scientific Officer since 2024, during which time he supported the Company’s growth, including the successful closing of its Series A financing, the expansion of the scientific team, and the advancement of its therapeutic programs. In his new role, he will lead ATB’s strategy and senior leadership team as the Company prepares to enter clinical deve
TREASoURcE Shows How Circular Economy Solutions Can Move Beyond Pilots Across Sectors and Regions19.5.2026 07:00:00 CEST | Press release
Across Europe, many circular economy solutions struggle to move beyond isolated pilots and into real-world deployment at scale. New approaches are needed that combine technical feasibility, market relevance and citizen engagement, while remaining adaptable to local contexts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260518914041/en/ TREASoURcE addressed circular economy challenges across energy, plastics and biobased side streams, combining technical solutions with stakeholder and citizen engagement. The EU-funded TREASoURcE project provides evidence that systemic, citizen-engaged circular economy solutions can be developed, tested and prepared for replication across regions. Using a common regional approach, the project combined real-life demonstrations, cross-value chain collaboration and early consideration of transferability to translate circular economy concepts into practical solutions in the fields of energy, mat
Azafaros Strengthens Leadership Team With Appointment of Amy Sullivan as Chief Financial Officer19.5.2026 07:00:00 CEST | Press release
Experienced biotech finance leader with over 30 years’ experience in capital markets and strategyProven track record in fundraising, M&A and company transformationCompany is currently running two pivotal Phase 3 studies with nizubaglustat in GM1/ GM2 gangliosidoses and Niemann-Pick type C disease Azafaros, a private company building a portfolio to become a leader in Lysosomal Storage Disorders and focused on addressing neurological symptoms, today announced that Amy Sullivan has joined the company as Chief Financial Officer. Ms. Sullivan brings more than 30 years’ experience in the life sciences sector, with expertise in capital raising, corporate strategy and communications. She joins Azafaros from IO Biotech, where she served as Chief Financial Officer. “Amy is a highly accomplished financial leader with a strong track record of supporting growth-stage biotech companies,” said Stefano Portolano, Chief Executive Officer at Azafaros. “Her expertise in financing, strategic positioning a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
